MobiHealth News February 20, 2024
Nathan Eddy

The company signed a research contract with the Office of the Director of National Intelligence’s Intelligence Advanced Research Projects Activity.

Detect-Ion, a startup focused on the detection and identification of chemical, biological, radiological, nuclear and explosive substances, announced it had secured a research contract with the Intelligence Advanced Research Projects Activity (IARPA), a government agency within the Office of the Director of National Intelligence, to develop a sensor to identify aerosol-based chemical threats.

The company will use the funding to develop a compact or “low-SWaP” (size, weight and power) sensor platform called Spectral to detect the presence of hazardous aerosols in complex urban environments.

Detect-Ion will leverage AI to help detect and identify aerosolized chemical threats and work with three...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices
Boston Scientific to acquire SoniVie for $540 million, expand hypertension treatment portfolio
Medicare Coverage Of Medical Technologies In A New Era
This year's top congressional medical technology priorities
Boston Scientific to acquire devicemaker: 3 things to know
Everything You Need To Know Before Getting An RFID Implant - 3

Share This Article